Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,530 GBX | +0.23% |
|
-4.35% | +5.47% |
06-28 | GSK reaches settlement over Zantac case in Illinois | AN |
06-28 | GSK Reaches Settlement in Illinois Zantac Lawsuit | DJ |
Sales 2024 * | 31.65B 40.02B 3,165B | Sales 2025 * | 33.64B 42.53B 3,364B | Capitalization | 62.37B 78.86B 6,237B |
---|---|---|---|---|---|
Net income 2024 * | 5.5B 6.95B 550B | Net income 2025 * | 6.49B 8.21B 649B | EV / Sales 2024 * | 2.35 x |
Net Debt 2024 * | 12.13B 15.33B 1,213B | Net Debt 2025 * | 8.69B 10.98B 869B | EV / Sales 2025 * | 2.11 x |
P/E ratio 2024 * |
11.5
x | P/E ratio 2025 * |
9.67
x | Employees | 70,212 |
Yield 2024 * |
3.97% | Yield 2025 * |
4.12% | Free-Float | 94.53% |
Latest transcript on GSK plc
1 day | +0.23% | ||
1 week | -4.35% | ||
Current month | -13.42% | ||
1 month | -12.10% | ||
3 months | -10.48% | ||
6 months | +4.67% | ||
Current year | +5.47% |
![Extreme 1484](/images/extremecours_fleche.png)
![Extreme 1484](/images/extremecours_fleche.png)
![Extreme 1453.2](/images/extremecours_fleche.png)
![Extreme 1302.6](/images/extremecours_fleche.png)
![Extreme 1280.92](/images/extremecours_fleche.png)
![Extreme 1280.92](/images/extremecours_fleche.png)
![Extreme 1280.92](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Emma Walmsley
CEO | Chief Executive Officer | 55 | 30/04/10 |
Julie Brown
DFI | Director of Finance/CFO | 62 | 30/04/23 |
James Ford
CMP | Compliance Officer | - | 31/07/95 |
Members of the board | Title | Age | Since |
---|---|---|---|
Julie Brown
DFI | Director of Finance/CFO | 62 | 30/04/23 |
Jonathan Symonds
CHM | Chairman | 66 | 31/08/19 |
Hal Barron
BRD | Director/Board Member | 62 | 31/12/17 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.17% | 11 M€ | +0.83% | - | |
3.15% | 21 M€ | +9.81% | - | |
2.51% | 7 M€ | +8.64% | - |
Date | Price | Change | Volume |
---|---|---|---|
28/06/24 | 1,530 | +0.23% | 8,074,724 |
27/06/24 | 1,526 | -4.60% | 10,696,970 |
26/06/24 | 1,600 | +0.28% | 5,248,816 |
25/06/24 | 1,595 | -0.84% | 9,780,496 |
24/06/24 | 1,608 | +0.59% | 18,591,250 |
Delayed Quote London S.E., June 28, 2024 at 04:35 pm
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.47% | 78.69B | |
+55.32% | 819B | |
-6.75% | 351B | |
+13.56% | 329B | |
+10.68% | 298B | |
+16.57% | 242B | |
+2.04% | 225B | |
+13.31% | 217B | |
+8.48% | 168B | |
-2.81% | 158B |
- Stock Market
- Equities
- GSK Stock